Makeup
BB & CC Creams
Blushers
Brushes & Tools
Concealers
Contouring Products
Eye Brow Products
Eye Primers
Eye Shadows
Face & Body Glitter
Face Powders
Face Primers
False Nails
Foundations
Highlighters
Lash Primers
Lash Products
Lip Glosses
Lip Liners
Lip Plumping Products
Lipsticks
Makeup Palettes
Makeup Setting Sprays
Nail Care Products
Nail Laquers
Randoms
Subscription Boxes
Skin Care
Anti Ageing Creams
Bath & Shower Products
Body Exfoliants
Body Moisturisers
Cleansers
Exfoliants & Masks
Eye Care Products
Face Moisturisers
Fake Tan Products
Foot Care Products
Hair Removal Products
Hand Care Products
Lip Care Products
Perfumes
Problem Skin Care Products
Sun Care Products
Toners
Hair Care
Conditioners
Hair Brushes & Accessories
Hair Colour Products
Hair Protection Products
Hair Styling Products
hair_treatment_and_masks
Heated Styling Tools
Scalp Care
Shampoos
Gift
Gift Sets
The Exceptional Vitamin C Booster is a four-week treatment pack for brighter, balanced and more luminous-looking skin. Powered by Noble Panacea’s expert OSMV™ Technology, the serum ensures that the active ingredient’s potency is preserved until application for optimal visible results. Featuring 20% pure L-ascorbic acid, the formula clarifies the complexion and reduces the appearance of discolouration and dark spots. Eight other sources of vitamin C, including camu camu, Kakadu plum and acerola, lend antioxidant protection to defend from dulling pollutants and environmental aggressors. Plus, mullein flower extract utilises its photoluminescent properties to absorb UV rays and reflect them, supporting noticeable radiance with a glowy, dew-kissed finish. Arriving in 30 pre-measured pouches to be mixed with your favourite serum. After 4 Weeks: 95% Skin complexion appears illuminated, bright, and healthy 97% Skin appears energised, revitalised, and boosted 97% Skin tone and texture is visibly more uniform 100% Skin feels protected and fortified against environmental aggressors -240% Reduction in visible pigmentation +162% Boost in radiance Clinical trials tested on 35 women.